Angel Investors · Apple Patent Applications · Apple patent claim · Apple Patent vs. Samsung · Business Idea Mobile App · Business Idea | Patent · Business News · Business Stock · Entrepreneurs · Equity · Infringement of Patents · inventors · Legal News · mobile app business start up · Mobile Application Development · Mobile Application Patent · patent attorney · Patent Attorney Expert · Patent Attorney USPTO · patent claims · patent drafting · Patent Expert · Patent Invalidity · patent invention · Patent Invention · Patent lawsuit · Patent Lawyers · patent prosecution · Patent Rights · Patent Search · patent specification · Patent Technologies · patent writing · patentability · patentable features · Patents · Product patents · protecting business idea · Samsung Patent · Samsung Patent Claims · scope of the invention · Smartphone adoption · Smartphone Patent · Smartphone Patent Application · software patents · Start ups · Start your own: Mobile apps business · US Patent Application · Venture Capital Funding · Venture Capital Investments · writing a patent application · Writing Patent Application

Apple v. Samsung – Patent Wars

Whenever we buy or use a smartphone, many of us ignore the fact that lot of research worth millions of dollars has gone behind creating such a smart device, that too for a span of many years. The only legitimate way available to such technology corporations for protecting their research work is to file for… Continue reading Apple v. Samsung – Patent Wars

Bayer's Cancer Drug · Compulsory Licensing in India · generics medicine · India IP Law firm · Legal News · Natco Pharma · Nexavar · Patent Rights

Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India

India Allows Compulsory Licensing of Bayer The decision is likely to open up the field for the generics industry or force innovative companies to make drugs more affordable. But will it also affect innovation? BioSpectrum explores the two sides of the story The globally watched case related to an Indian pharma company's request to the… Continue reading Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India